Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Dagan

Showing results (281-290 of 367) with videos related to

Pageof 37
Sort By:
Emerging Infectious Diseases|February 21, 2018
Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, IsraelAssaf Rokney, Shalom Ben-Shimol, Zinaida Korenman, et al.
Plos One|February 12, 2014
Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in IsraelGili Regev-Yochay, Galia Rahav, Klaris Riesenberg, et al.
Expert Review of Vaccines|June 16, 2026
Post-pandemic impact on the epidemiology of invasive pneumococcal disease: consensus statement from the Latin American Society of Pediatric Infectious Diseases (SLIPE)Roberto Debbag, María L Ávila-Agüero, Angela Gentile, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2021
Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort StudyDana Danino, Shalom Ben-Shimol, Bart Adriaan van der Beek, et al.
International Immunology|July 4, 2008
Contribution of IL-1 to resistance to Streptococcus pneumoniae infectionDaniel Kafka, Eduard Ling, Galia Feldman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2021
Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective SurveillanceShalom Ben-Shimol, Gili Regev-Yochay, Noga Givon-Lavi, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonizationChristine Juergens, Scott Patterson, James Trammel, et al.
The Journal of Infectious Diseases|October 31, 2014
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniaeRon Dagan, Christine Juergens, James Trammel, et al.
Vaccine|June 14, 2003
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infantsLuis Jódar, Jay Butler, George Carlone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2011
Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription studyGili Regev-Yochay, Meir Raz, Ron Dagan, et al.
Pageof 37

Showing results (281-290 of 367) with videos related to

Sort By:
Pageof 37
Emerging Infectious Diseases|February 21, 2018
Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, IsraelAssaf Rokney, Shalom Ben-Shimol, Zinaida Korenman, et al.
Plos One|February 12, 2014
Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in IsraelGili Regev-Yochay, Galia Rahav, Klaris Riesenberg, et al.
Expert Review of Vaccines|June 16, 2026
Post-pandemic impact on the epidemiology of invasive pneumococcal disease: consensus statement from the Latin American Society of Pediatric Infectious Diseases (SLIPE)Roberto Debbag, María L Ávila-Agüero, Angela Gentile, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2021
Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort StudyDana Danino, Shalom Ben-Shimol, Bart Adriaan van der Beek, et al.
International Immunology|July 4, 2008
Contribution of IL-1 to resistance to Streptococcus pneumoniae infectionDaniel Kafka, Eduard Ling, Galia Feldman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2021
Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective SurveillanceShalom Ben-Shimol, Gili Regev-Yochay, Noga Givon-Lavi, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2014
Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonizationChristine Juergens, Scott Patterson, James Trammel, et al.
The Journal of Infectious Diseases|October 31, 2014
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniaeRon Dagan, Christine Juergens, James Trammel, et al.
Vaccine|June 14, 2003
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infantsLuis Jódar, Jay Butler, George Carlone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2011
Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription studyGili Regev-Yochay, Meir Raz, Ron Dagan, et al.
Pageof 37